IQVIA Career

My Lilly career was an incredible learning experience in every dimension: science, medicine development, and global management, teamwork and leadership. After taking an early retirement package from Lilly, I was eager to find additional opportunities that would leverage all aspects of what I had learned. That opportunity came through my role as Vice-President of Strategic Operations, and then Global Regulatory Affairs at IQVIA. The business unit was small and poised for growth when I joined. Working with a global team of highly seasoned professionals, I led a strategic refresh that enabled growth in the revenue, capabilities, geographic footprint, and strategic partnerships of the business.

During this time, I had the good fortune to also be a member of an executive team with responsibilities for a broad array of drug development functions (Data Management, Stats, Medical Affairs, Safety, Medical Writing, Regulatory and Safety Technology), with a very broad geographic presence.

This role also covered the SARS-CoV-2 pandemic period, and my business unit rapidly pivoted to adapt to global regulatory accelerated process, working tirelessly with hundreds of pharma companies, to enable rapid regulatory progression around the world towards testing of a wide variety of interventions needed to address the pandemic.